GO:0001922 [B-1 B cell homeostasis]
GO:0002020 [protease binding]
GO:0002237 [response to molecule of bacterial origin]
GO:0002634 [regulation of germinal center formation]
GO:0002677 [negative regulation of chronic inflammatory response]
GO:0003677 [DNA binding]
GO:0004221 [ubiquitin thiolesterase activity]
GO:0004842 [ubiquitin-protein ligase activity]
GO:0004843 [ubiquitin-specific protease activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005737 [cytoplasm]
GO:0005764 [lysosome]
GO:0005813 [centrosome]
GO:0005829 [cytosol]
GO:0006508 [proteolysis]
GO:0006915 [apoptotic process]
GO:0006954 [inflammatory response]
GO:0008270 [zinc ion binding]
GO:0016579 [protein deubiquitination]
GO:0019900 [kinase binding]
GO:0031397 [negative regulation of protein ubiquitination]
GO:0032088 [negative regulation of NF-kappaB transcription factor activity]
GO:0032480 [negative regulation of type I interferon production]
GO:0032495 [response to muramyl dipeptide]
GO:0032691 [negative regulation of interleukin-1 beta production]
GO:0032703 [negative regulation of interleukin-2 production]
GO:0032715 [negative regulation of interleukin-6 production]
GO:0032720 [negative regulation of tumor necrosis factor production]
GO:0034136 [negative regulation of toll-like receptor 2 signaling pathway]
GO:0034140 [negative regulation of toll-like receptor 3 signaling pathway]
GO:0034144 [negative regulation of toll-like receptor 4 signaling pathway]
GO:0034148 [negative regulation of toll-like receptor 5 signaling pathway]
GO:0035871 [protein K11-linked deubiquitination]
GO:0035872 [nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway]
GO:0043066 [negative regulation of apoptotic process]
GO:0043124 [negative regulation of I-kappaB kinase/NF-kappaB signaling]
GO:0043130 [ubiquitin binding]
GO:0043621 [protein self-association]
GO:0045087 [innate immune response]
GO:0045732 [positive regulation of protein catabolic process]
GO:0045736 [negative regulation of cyclin-dependent protein serine/threonine kinase activity]
GO:0045779 [negative regulation of bone resorption]
GO:0045824 [negative regulation of innate immune response]
GO:0048662 [negative regulation of smooth muscle cell proliferation]
GO:0050691 [regulation of defense response to virus by host]
GO:0050728 [negative regulation of inflammatory response]
GO:0050869 [negative regulation of B cell activation]
GO:0051259 [protein oligomerization]
GO:0060548 [negative regulation of cell death]
GO:0061043 [regulation of vascular wound healing]
GO:0070301 [cellular response to hydrogen peroxide]
GO:0070423 [nucleotide-binding oligomerization domain containing signaling pathway]
GO:0070429 [negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway]
GO:0070433 [negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway]
GO:0070536 [protein K63-linked deubiquitination]
GO:0070936 [protein K48-linked ubiquitination]
GO:0071108 [protein K48-linked deubiquitination]
GO:0071222 [cellular response to lipopolysaccharide]
GO:0072573 [tolerance induction to lipopolysaccharide]
GO:0090291 [negative regulation of osteoclast proliferation]
GO:1902042 [negative regulation of extrinsic apoptotic signaling pathway via death domain receptors]
GO:2000347 [positive regulation of hepatocyte proliferation]
GO:2000349 [negative regulation of CD40 signaling pathway]
GO:2000352 [negative regulation of endothelial cell apoptotic process]
